{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:32:17Z","timestamp":1790353937396,"version":"4.1.0"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"18","license":[{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5,2]]},"abstract":"<jats:p>The role of the number of negative lymph nodes (NLNs) removed on survival and tumor recurrence after surgery in patients with non-small-cell lung cancer (NSCLC) is still unclear. This study aimed to evaluate the effect of the number of NLNs on overall survival (OS), recurrence-free survival (RFS), and recurrence rate of patients with NSCLC after surgery. This multicenter retrospective cohort study examined the medical profile of 1002 patients with a definite diagnosis of NSCLC who underwent surgery between 2021 and 2023 at one of our medical centers. Patients with NSCLC were classified into 4 groups based on the number of NLNs removed during surgery as follows. I: &lt;10 (196 patients); II: 10 to 19 (341 patients); III: 20 to 30 (267 patients); and IV: &gt;30 NLN (198 patients). The patients\u2019 demographics, tumor characteristics, and pathological findings were obtained by reviewing their medical records. The 5-year survival rate was 36.1%. The OS rate in groups I, II, III, and IV patients was 14%, 25%, 33%, and 43%, respectively (log-rank\u2005=\u2005161.2, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.001). Also, the RFS rate in patients of groups V\/III was significantly higher than in groups I\/II (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05). Multivariate analysis showed that the OS rate in group V and II patients was significantly higher than the other 2 groups (I and II). In addition, age\u2005&gt;\u200565 years, comorbidity, tumor size\u2005&gt;\u20053, advanced tumor stage, presence of metastasis, lymph node ratio\u2005&gt;\u20050.3, total lobectomy, central tumor, and no adjuvant chemotherapy are significantly associated with decreased OS rate of patients with NSCLC. The increase in the number of NLNs removed during surgery was associated with an increase in the OS and RFS rates. Attention to this number can be a key factor in improving the survival prediction of patients with NSCLC.<\/jats:p>","DOI":"10.1097\/md.0000000000042402","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T22:05:27Z","timestamp":1746482727000},"page":"e42402","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Effect of the number of negative lymph nodes removed on the survival and recurrence rate patients with non-small-cell lung cancer undergoing surgery: A multicenter retrospective cohort study"],"prefix":"10.1097","volume":"104","author":[{"given":"Mansour","family":"Bahardoust","sequence":"first","affiliation":[{"name":"Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran"},{"name":"Colorectal Research Center, Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyal","family":"Yarahmadi","sequence":"additional","affiliation":[{"name":"School of Medicine, Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behnaz","family":"Niroomand","sequence":"additional","affiliation":[{"name":"School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabnam","family":"Rashidi","sequence":"additional","affiliation":[{"name":"School of Medicine, Medical University of Lublin, Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Daneshfar","sequence":"additional","affiliation":[{"name":"School of Medicine, Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meisam","family":"Haghmoradi","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Urmia University of Medical Sciences, Urmia, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak","family":"Goodarzy","sequence":"additional","affiliation":[{"name":"School of Medicine, Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4384-6543","authenticated-orcid":false,"given":"Adnan","family":"Tizmaghz","sequence":"additional","affiliation":[{"name":"Firoozabadi Clinical Research Development Unit (F A CRD U), Iran University of Medical Sciences (IUMS), Tehran, Iran."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250513","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20250513","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018.","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R3-20250513","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012.","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"R5-20250513","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/ejso.2002.1239","article-title":"Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer.","volume":"28","author":"Van der Wal","year":"2002","journal-title":"Eur J Surg Oncol"},{"key":"R6-20250513","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1245\/s10434-011-2189-y","article-title":"Prognostic value of number of removed lymph nodes, number of involved lymph nodes, and lymph node ratio in 7502 breast cancer patients enrolled onto trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG).","volume":"19","author":"Tausch","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"R7-20250513","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/jcp.2003.015560","article-title":"Node retrieval in axillary lymph node dissections: recommendations for minimum numbers to be confident about node negative status.","volume":"57","author":"Somner","year":"2004","journal-title":"J Clin Pathol"},{"key":"R8-20250513","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1200\/JCO.2008.18.6965","article-title":"Lymph node ratio as an alternative to pN staging in node-positive breast cancer.","volume":"27","author":"Vinh-Hung","year":"2009","journal-title":"J Clin Oncol"},{"key":"R9-20250513","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1245\/s10434-011-2012-9","article-title":"Lymph node ratio should be considered for incorporation into staging for breast cancer.","volume":"18","author":"Chagpar","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"R10-20250513","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s10549-011-1730-9","article-title":"Lymph node ratio and pN staging in patients with node-positive breast cancer: a report from the Korean breast cancer society.","volume":"130","author":"Ahn","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"R11-20250513","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1200\/JCO.2006.09.8152","article-title":"The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer.","volume":"25","author":"Karlsson","year":"2007","journal-title":"J Clin Oncol"},{"key":"R12-20250513","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s11748-020-01345-y","article-title":"Lymph node assessment in early stage non-small cell lung cancer lymph node dissection or sampling?","volume":"68","author":"Darling","year":"2020","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"R13-20250513","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1378\/chest.36.4.343","article-title":"Mediastinoscopy: a method for inspection and tissue biopsy in the superior mediastinum.","volume":"36","author":"Carlens","year":"1959","journal-title":"Dis Chest"},{"key":"R14-20250513","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.lungcan.2004.11.006","article-title":"Poor correspondence between clinical and pathologic staging in stage 1 non-small cell lung cancer: results from CALGB 9761, a prospective trial.","volume":"48","author":"D\u2019Cunha","year":"2005","journal-title":"Lung Cancer"},{"key":"R15-20250513","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1378\/chest.10-0859","article-title":"Number of lymph nodes harvested from a mediastinal lymphadenectomy: results of the randomized, prospective American College of Surgeons Oncology Group Z0030 trial.","volume":"139","author":"Darling","year":"2011","journal-title":"Chest"},{"key":"R16-20250513","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-015-1061-z","article-title":"Number of negative lymph nodes is associated with disease-free survival in patients with breast cancer.","volume":"15","author":"Wu","year":"2015","journal-title":"BMC Cancer"},{"key":"R17-20250513","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.ejso.2006.06.005","article-title":"Prognostic significance of total number of nodes removed, negative nodes removed, and ratio of positive nodes to removed nodes in node positive breast carcinoma.","volume":"32","author":"Kuru","year":"2006","journal-title":"Eur J Surg Oncol"},{"key":"R18-20250513","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1245\/s10434-014-3665-y","article-title":"Number of negative lymph nodes is associated with survival in thoracic esophageal squamous cell carcinoma patients undergoing three-field lymphadenectomy.","volume":"21","author":"Zhu","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"R19-20250513","first-page":"844","article-title":"Number of negative lymph nodes should be considered for incorporation into staging for breast cancer.","volume":"5","author":"Wu","year":"2015","journal-title":"Am J Cancer Res"},{"key":"R20-20250513","doi-asserted-by":"crossref","first-page":"261","DOI":"10.7150\/jca.10402","article-title":"Number of negative lymph nodes can predict survival after postmastectomy radiotherapy according to different breast cancer subtypes.","volume":"6","author":"Wu","year":"2015","journal-title":"J Cancer"},{"key":"R21-20250513","doi-asserted-by":"crossref","first-page":"6961","DOI":"10.2147\/CMAR.S187857","article-title":"Positive relationship between number of negative lymph nodes and duration of gallbladder cancer cause-specific survival after surgery.","volume":"10","author":"Lin","year":"2018","journal-title":"Cancer Manag Res"},{"key":"R22-20250513","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1200\/JCO.2003.07.010","article-title":"Effect of number of lymph nodes sampled on outcome in patients with stage I non\u2013small-cell lung cancer.","volume":"21","author":"Gajra","year":"2003","journal-title":"J Clin Oncol"},{"key":"R23-20250513","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1378\/chest.128.3.1545","article-title":"Postoperative survival and the number of lymph nodes sampled during resection of node-negative non-small cell lung cancer.","volume":"128","author":"Ludwig","year":"2005","journal-title":"Chest"},{"key":"R24-20250513","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/01243894-200602000-00004","article-title":"Significance of the number of positive lymph nodes in resected non-small cell lung cancer.","volume":"1","author":"Fukui","year":"2006","journal-title":"J Thorac Oncol"},{"key":"R25-20250513","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/JTO.0b013e31817dfced","article-title":"Prognostic significance of the number of lymph nodes removed at lobectomy in stage IA non-small cell lung cancer.","volume":"3","author":"Ou","year":"2008","journal-title":"J Thorac Oncol"},{"key":"R26-20250513","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.lungcan.2009.02.024","article-title":"A novel clinical prognostic score incorporating the number of resected lymph-nodes to predict recurrence and survival in non-small-cell lung cancer.","volume":"66","author":"Bria","year":"2009","journal-title":"Lung Cancer"},{"key":"R27-20250513","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1097\/JTO.0b013e31822a35c3","article-title":"Prognostic impact of number of resected and involved lymph nodes at complete resection on survival in non-small cell lung cancer.","volume":"6","author":"Saji","year":"2011","journal-title":"J Thorac Oncol"},{"key":"R28-20250513","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/JTO.0b013e3181ff9b45","article-title":"Which is the better prognostic factor for resected non-small cell lung cancer: the number of metastatic lymph nodes or the currently used nodal stage classification?","volume":"6","author":"Wei","year":"2011","journal-title":"J Thorac Oncol"},{"key":"R29-20250513","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s11605-009-0919-2","article-title":"The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.","volume":"13","author":"Riediger","year":"2009","journal-title":"J Gastrointest Surg"},{"key":"R30-20250513","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/SLA.0000000000003123","article-title":"Timing but not patterns of recurrence is different between node-negative and node-positive resected pancreatic cancer.","volume":"272","author":"Honselmann","year":"2020","journal-title":"Ann Surg"},{"key":"R31-20250513","first-page":"77","article-title":"Survival of metastatic gastric cancer: significance of age, sex and race\/ethnicity.","volume":"2","author":"Yang","year":"2011","journal-title":"J Gastrointest Oncol"},{"key":"R32-20250513","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/annonc\/mdp290","article-title":"Race and ethnicity correlate with survival in patients with gastric adenocarcinoma.","volume":"21","author":"Kim","year":"2010","journal-title":"Ann Oncol"},{"key":"R33-20250513","doi-asserted-by":"crossref","first-page":"79387","DOI":"10.18632\/oncotarget.18154","article-title":"Prognostic value of number of negative lymph node in patients with stage II and IIIa non-small cell lung cancer.","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"R34-20250513","first-page":"46","article-title":"Five-year survival and prognostic factors according to histology in 6101 non-small-cell lung cancer patients.","volume":"77","author":"Molinier","year":"2020","journal-title":"Respir Med Res"},{"key":"R35-20250513","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1093\/ejcts\/ezz384","article-title":"Prognostic factors of oligometastatic non-small-cell lung cancer following radical therapy: a multicentre analysis.","volume":"57","author":"Opitz","year":"2020","journal-title":"Eur J Cardiothorac Surg"},{"key":"R36-20250513","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12885-020-6621-1","article-title":"Clinicopathological variables influencing overall survival, recurrence and post-recurrence survival in resected stage I non-small-cell lung cancer.","volume":"20","author":"Wang","year":"2020","journal-title":"BMC Cancer"},{"key":"R37-20250513","doi-asserted-by":"crossref","first-page":"7481","DOI":"10.1245\/s10434-023-14016-y","article-title":"Prognostic factors for survival of stage IB non-small cell lung cancer patients: a 10-year follow-up retrospective study.","volume":"30","author":"Yang","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"R38-20250513","doi-asserted-by":"crossref","first-page":"10563","DOI":"10.1002\/cam4.5791","article-title":"Survival and prognostic factors of early\u2010stage non\u2010small cell lung cancer in Central and Eastern Europe: a prospective cohort study.","volume":"12","author":"Sheikh","year":"2023","journal-title":"Cancer Med"},{"key":"R39-20250513","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/JCMA.0000000000001050","article-title":"Prognostic factors for recurrence-free survival in resected pathologic N2-stage III non-small cell lung cancer treated with upfront surgery.","volume":"87","author":"Tsai","year":"2024","journal-title":"J Chin Med Assoc"},{"key":"R40-20250513","doi-asserted-by":"crossref","first-page":"1377281","DOI":"10.3389\/fonc.2024.1378135","article-title":"Prognostic factors and predictive model construction in patients with non-small cell lung cancer: a retrospective study.","volume":"14","author":"Ma","year":"2024","journal-title":"Front Oncol"},{"key":"R41-20250513","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00408-020-00378-7","article-title":"Negative lymph node count predicts survival of resected non-small cell lung cancer.","volume":"198","author":"Zhou","year":"2020","journal-title":"Lung"},{"key":"R42-20250513","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/COC.0000000000001006","article-title":"Prognostic relevance of negative lymph node count in resected stage I\u2013IIIa small-cell lung cancer.","volume":"46","author":"Yang","year":"2023","journal-title":"Am J Clin Oncol"},{"key":"R43-20250513","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.1177\/00031348221114034","article-title":"Negative lymph node is an independent prognostic factor for stage III gastric cancer patients after curative gastrectomy: a surveillance, epidemiology, and end results-based study.","volume":"89","author":"Liu","year":"2023","journal-title":"Am Surg"},{"key":"R44-20250513","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12893-023-02154-9","article-title":"Effect of the number of negative lymph nodes removed on the survival and recurrence rate after gastrectomy in patients with gastric cancer: a multicenter retrospective cohort study.","volume":"23","author":"Bahardoust","year":"2023","journal-title":"BMC Surg"},{"key":"R45-20250513","doi-asserted-by":"crossref","first-page":"962282","DOI":"10.3389\/fonc.2022.962282","article-title":"Clinical impact of number of lymph nodes dissected on postoperative survival in node-negative small cell lung cancer.","volume":"12","author":"Takamori","year":"2022","journal-title":"Front Oncol"},{"key":"R46-20250513","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/COC.0000000000000379","article-title":"Influence of extent of lymph node evaluation on survival for pathologically lymph node negative non\u2013small cell lung cancer.","volume":"41","author":"Becker","year":"2018","journal-title":"Am J Clin Oncol"},{"key":"R47-20250513","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.athoracsur.2013.09.058","article-title":"Number of lymph nodes associated with maximal reduction of long-term mortality risk in pathologic node-negative non\u2013small cell lung cancer.","volume":"97","author":"Osarogiagbon","year":"2014","journal-title":"Ann Thorac Surg"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042402","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T22:03:33Z","timestamp":1747173813000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,2]]},"references-count":46,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042402","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,2]]}}}